Курс акций HAEMATO AG Inhaber-Akt Nach Kapitalherabsetzung в EUR
Биржа |
|
|
|
|
20,20
Последний
|
0
Объём
|
|
Профиль HAEMATO AG Inhaber-Akt Nach Kapitalherabsetzung
Подробнее
Haemato AG engages in the pharmaceutical industry. It focuses on growth markets of patent-free, and patented medicinal products in the insurance-financed market. Its portfolio include therapies for cancer, HIV, rheumatology, and other chronic diseases, and products for the privately financed market for aesthetic treatments. The company was founded on May 10, 1993 and is headquartered in Schönefeld, Germany.